Merck announced that it has launched a clinical trial network to increase the productivity and effectiveness of its growing oncology division. Rather than hire a new team of investigators for every clinical trial it conducts, Merck created a network of experienced investigators who have had the opportunity to see many of the company’s molecules, know the patient community very well, and are aware of the problems Merck is trying to solve.Merck also gains access to the investigator’s intellectual skills and capabilities as well as access to new technologies and ideas.“We wanted to have a longitudinal relationship with the investigators, where they would get to know our pipeline well and can help us evaluate it—not just run one-off clinical trials,” said Eliav Barr, vice president of projects and pipeline management, Oncology, Merck Research Laboratories. “If they know the drugs really well, and they know what we have in the pipeline, and they know our personalized medicine needs—both in the short and long term—then we can develop programs that are designed to compare drugs better or to pick the winners from drugs entering Phase I trials.”.............&more
No comments:
Post a Comment